Literature DB >> 31011838

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.

Thwe Htay1, Kyaw Soe2, Arianna Lopez-Perez3, Amy HoangAnh Doan3, Michael A Romagosa3, KoKo Aung3.   

Abstract

PURPOSE OF REVIEW: The aims of this review are to summarize recent data on mortality and cardiovascular disease (CVD) in type 1 and type 2 diabetes and to determine the interventions that could have contributed to a reduction in mortality. RECENT
FINDINGS: Recent studies found a downward trend in mortality and CVD among both diabetics and non-diabetics worldwide over the last few decades. The decline among diabetics is steeper than that among non-diabetics. Despite a parallel trend of decline, an approximately twofold difference in mortality and CVD between the two populations remains. A greater emphasis on glycemic control, management of cardiovascular risk factors, quality improvement programs, and advances in treatment of conditions associated diabetes are the factors that potentially contributed to the improvement. Although the trend is encouraging, a rising prevalence of diabetes will continue the absolute disease burden to the society. Future interventions should focus on prevention of diabetes.

Entities:  

Keywords:  Cardiovascular disease; Cardiovascular mortality; Cardiovascular risk; Diabetes mellitus, type 1; Diabetes mellitus, type 2; Mortality; Trend

Mesh:

Year:  2019        PMID: 31011838     DOI: 10.1007/s11886-019-1133-9

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  14 in total

1.  Serum Cortisol, 25 (OH)D, and Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus.

Authors:  Yuxi Jin; Dandan Wei; Pengling Liu; Fei Chen; Rongrong Li; Jinyu Zhang; Ruyi Zhang; Zuoxiang Liu; Wenqian Huo; Linlin Li; Chongjian Wang; Jinbao Ban; Zhenxing Mao
Journal:  Int J Endocrinol       Date:  2022-06-18       Impact factor: 2.803

2.  Evaluation of clinical efficacy of continuous care with improved insulin injection techniques on patients with diabetes mellitus: a randomized controlled trial.

Authors:  Fang-Ying Zhang; Mengyuan Shen; Li-Qin Sun
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

Review 3.  Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits.

Authors:  Meghan E Pauley; Kalie L Tommerdahl; Janet K Snell-Bergeon; Gregory P Forlenza
Journal:  Curr Cardiol Rep       Date:  2022-10-24       Impact factor: 3.955

4.  The Effect of Diacerein on Type 2 Diabetic Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis.

Authors:  Shizhe Guo; Xianshan Guo; Hongya Zhang; Xuan'e Zhang; Zhen Li
Journal:  J Diabetes Res       Date:  2020-02-10       Impact factor: 4.011

5.  Diagnostic significance of serum FGD5-AS1 and its predictive value for the development of cardiovascular diseases in patients with type 2 diabetes.

Authors:  Yongdi Wang; Jian Wang
Journal:  Diabetol Metab Syndr       Date:  2022-01-28       Impact factor: 3.320

6.  Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia.

Authors:  Antonio J Martínez-Ortega; Cristina Muñoz-Gómez; Noelia Gros-Herguido; Pablo Jesús Remón-Ruiz; Domingo Acosta-Delgado; Fernando Losada-Viñau; Alfonso Pumar-López; Miguel Ángel Mangas-Cruz; Irene González-Navarro; Gema López-Gallardo; Virginia Bellido; Alfonso Manuel Soto-Moreno
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

7.  Disease Burden and Healthcare Costs for T2D Patients With and Without Established Cardiovascular Disease in Sweden: A Retrospective Cohort Study.

Authors:  Lars Bernfort; Magnus Husberg; Ann-Britt Wiréhn; Ulf Rosenqvist; Staffan Gustavsson; Kristina Karlsdotter; Lars-Åke Levin
Journal:  Diabetes Ther       Date:  2020-05-28       Impact factor: 2.945

8.  Socioeconomic inequalities in type 2 diabetes in employed individuals, nonworking spouses and pensioners.

Authors:  Batoul Safieddine; Stefanie Sperlich; Johannes Beller; Karin Lange; Jelena Epping; Juliane Tetzlaff; Fabian Tetzlaff; Siegfried Geyer
Journal:  SSM Popul Health       Date:  2020-05-11

9.  Dihydromyricetin Improves Endothelial Dysfunction in Diabetic Mice via Oxidative Stress Inhibition in a SIRT3-Dependent Manner.

Authors:  Yu-Yun Hua; Yue Zhang; Wei-Wei Gong; Yue Ding; Jie-Ru Shen; Hua Li; Yun Chen; Guo-Liang Meng
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923

10.  Empagliflozin Alleviates Left Ventricle Hypertrophy in High-Fat-Fed Mice by Modulating Renin Angiotensin Pathway.

Authors:  Juliana Cordovil Cotrin; Gabriel Santos Martins de Souza; Tamiris Ingrid Petito-da-Silva; Luiz Eduardo Macedo Cardoso; Vanessa Souza-Mello; Sandra Barbosa-da-Silva
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2022-01-18       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.